Fellows of the British Pharmacological Society are members who have demonstrated distinction and peer recognition in pharmacology.
Fellows have made, and may continue to make, substantial contributions to the disciplines of pharmacology, clinical pharmacology and therapeutics, through their work, publication and presentation of research, leadership, and contribution to Society life.
Find out more and apply for Fellowship.
This directory has been created to increase the visibility of our Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Fellows with similar areas of interest.
Here you can find profiles of each Fellow, including information on their institutional affiliation, year elected, primary professional setting, affinity group membership, and a short biography.
Select the magnifying glass icon to begin any searches.
Dyfrig graduated in pharmacy at Cardiff University before undertaking a PhD in cardiovascular pharmacology at the University of Liverpool.
My main employment was with the Department of Pharmacology, University of Leeds with significant periods in Australia, Guyana, Kuwait, Saudi Arabia and Egypt.
Laura Humphrys is a researcher interested in all things surrounding G protein coupled receptor (GPCR) pharmacology, particularly in the translation between structure to biochemistry to (patho)physiology.
Graduated with a degree in Pharmacology from Kings College London in 1988 and was awarded a PhD from the University of Wales in 1994.
Academic biochemical pharmacologist and pharmacogeneticist.
Dr Insel received an MD from the University of Michigan and post-MD training at Boston City Hospital/Harvard Medical Service, NIH and UC San Francisco (UCSF).
Professor Ambrose O Isah graduated from the University of Ibadan Medical School in 1979, He obtained his doctorate degree (MD) in 1995 at the Wolfson Unit of Clinical Pharmacology, University of Newcastle Upon Tyne, United Kingdom.
Angelo is full professor (Pharmacology) at the Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II.
Mike has extensive experience in all phases of drug discovery research from target identification and validation through drug candidate selection and clinical development including Phase-II proof of concept studies and drug life-cycle management.